glipizide has been researched along with Diabetes Mellitus, Type 1 in 11 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with type 1 diabetes mellitus a quality of life decreases gradually with the duration of diabetes." | 2.41 | [The effect of improved glycemic control on quality of life in patients with type I and type II diabetes]. ( Grzeszczak, W, 2001) |
| "Cryptococcosis is an opportunistic infection caused by Cryptococcus neoformans that typically presents in immunocompromised patients, most commonly in those with human immunodeficiency virus (HIV) infection." | 1.40 | Disseminated cryptococcosis in a diabetic patient. ( Khatu, S; Poojary, S, 2014) |
| "Insulin-dependent diabetes mellitus (IDDM) is associated with the formation of autoantibodies against different antigens in the islets of Langerhans, so-called islet cell antibodies (ICA)." | 1.29 | Modulation of beta-cell activity and its influence on islet cell antibody (ICA) and islet cell surface antibody (ICSA) reactivity. ( Björk, E; Grawé, J; Hallberg, A; Kämpe, O; Karlsson, FA; Norheim, I, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poojary, S | 1 |
| Khatu, S | 1 |
| Noczyńska, A | 1 |
| Zubkiewicz-Kucharska, A | 1 |
| Salmonowicz, B | 1 |
| Małecki, M | 2 |
| Młynarski, W | 1 |
| Klupa, T | 1 |
| Skupień, J | 1 |
| Szalecki, M | 1 |
| Jałowiec, I | 1 |
| Surdej, B | 1 |
| Myśliwiec, M | 1 |
| Sieradzki, J | 1 |
| Pontiroli, AE | 1 |
| Alberetto, M | 1 |
| Bertoletti, A | 1 |
| Baio, G | 1 |
| Pozza, G | 1 |
| Björk, E | 1 |
| Kämpe, O | 1 |
| Grawé, J | 1 |
| Hallberg, A | 1 |
| Norheim, I | 1 |
| Karlsson, FA | 1 |
| Selam, JL | 1 |
| Woertz, L | 1 |
| Lozano, J | 1 |
| Robinson, M | 1 |
| Chan, E | 1 |
| Charles, MA | 1 |
| Sharma, A | 1 |
| Kharb, S | 1 |
| Chugh, SN | 1 |
| Kakkar, R | 1 |
| Singh, GP | 1 |
| Grzeszczak, W | 1 |
| Whittington, KB | 1 |
| Solomon, SS | 1 |
| Lu, ZN | 1 |
| Selawry, HP | 1 |
| Lins, PE | 1 |
| Kollind, M | 1 |
| Adamson, U | 1 |
| Gerich, JE | 1 |
2 reviews available for glipizide and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
[The effect of improved glycemic control on quality of life in patients with type I and type II diabetes].
Topics: Adaptation, Psychological; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glipizide; Humans; | 2001 |
Sulfonylureas in the treatment of diabetes mellitus--1985.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Comb | 1985 |
3 trials available for glipizide and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
The use of glipizide combined with intensive insulin treatment for the induction of remissions in new onset adult type I diabetes.
Topics: Adult; Age of Onset; Algorithms; Blood Glucose; C-Peptide; Combined Modality Therapy; Diabetes Melli | 1993 |
Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Femal | 2000 |
Glipizide does not affect absorption of glucose and xylose in diabetics without residual beta-cell function.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glipizide; Gl | 1986 |
6 other studies available for glipizide and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Disseminated cryptococcosis in a diabetic patient.
Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diabetes Mellitus, | 2014 |
[Three-year observation of permanent neonatal diabetes].
Topics: Adolescent; Adult; ATP-Binding Cassette Transporters; Child; Diabetes Mellitus, Type 1; Female; Glip | 2010 |
[Glycemic index of meals and postprandial glycemia in patients with permanent neonatal diabetes due to Kir6.2 gene mutations].
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Child; Diabetes Mellitus, Type 1; Glipizide; Glycemic | 2007 |
Sulfonylureas enhance in vivo the effectiveness of insulin in type 1 (insulin dependent) diabetes mellitus.
Topics: Adolescent; Adult; Chlorpropamide; Diabetes Mellitus, Type 1; Drug Interactions; Female; Glipizide; | 1984 |
Modulation of beta-cell activity and its influence on islet cell antibody (ICA) and islet cell surface antibody (ICSA) reactivity.
Topics: Animals; Autoantibodies; Diabetes Mellitus, Type 1; Diazoxide; Flow Cytometry; Glipizide; Humans; Im | 1993 |
Islet allografts in the cryptorchid testes of spontaneously diabetic BB/Wor dp rats: response to glucose, glipizide, and arginine.
Topics: Animals; Arginine; Cryptorchidism; Diabetes Mellitus, Type 1; Glipizide; Glucagon; Glucose; Glucose | 1991 |